Latest Corporate News
Noble Corporation PLC Reports Strong Q1 2026 Results
Noble Corporation announced Q1 2026 net income of $121 million, adjusted EBITDA of $277 million, and declared a $0.50 per share Q2 dividend. Backlog reached $7.5 billion as of April 27, including $565 million in new contracts like a 3-year extension for Noble Courage and 5-well deal for Noble Deliverer. Full-year revenue guidance maintained at $2.8-3B, with capex increased to $615-665M.
Intellia Therapeutics to Unveil Phase 3 HAELO Trial Data
Intellia will report topline data from its global Phase 3 HAELO trial of lonvoguran ziclumeran for hereditary angioedema on April 27, 2026, marking the first Phase 3 readout for an in vivo CRISPR candidate. A webcast is scheduled at 8:00 a.m. ET to discuss results. Investors can join via the company's website.
US Warns of Alleged AI Thefts by China
The US has warned of intellectual property thefts in AI by China, amid growing autonomy like DeepSeek's V4 model for Huawei chips. Western governments have banned DeepSeek in institutions over privacy concerns, yet it remains popular on open-source platforms. This highlights escalating tech rivalry.
Taiwan Approves Google's NT$27.08 Billion Investment
Taiwan's government approved Google's NT$27.08 billion (US$860M) investment, mainly for data processing, electronic info services, and semiconductor inventory procurement. Funds will go through Google’s Singapore subsidiary to Charter Investments Ltd. This is Google's second year increasing Taiwan investments.
Micron Pushes US Congress for Chip Equipment Export Curbs on China
Micron is advocating for the 'MATCH Act' to impose new export restrictions on chipmaking equipment to Chinese competitors like ChangXin Memory Technologies. A US House panel is voting on the bill to align foreign firms with US curbs on companies like Lam Research. This aims to close gaps in current restrictions.
Telix Pharmaceuticals Tops ASX Most Shorted Shares at 16.2%
Telix Pharmaceuticals (ASX: TLX) became the most shorted ASX stock with 16.2% short interest, as sellers bet against US FDA approval for new radiopharmaceutical products. Short positions rose significantly week-on-week per ASIC data. This reflects investor skepticism on regulatory outcomes.
Domino's Pizza Enterprises Short Interest Rises to 15.6%
Domino's Pizza (ASX: DMP) saw short interest climb to 15.6%, with doubts surrounding its turnaround strategy. Short sellers are targeting the pizza chain operator amid ongoing challenges. ASIC's weekly report highlights it as the second most shorted.
PolyNovo Short Interest at 14% on High Earnings Multiples
PolyNovo (ASX: PNV), a medical device firm, has 14% shares shorted, up from last week, due to trading on elevated earnings multiples. Investors view it as potentially overvalued. This positions it third on ASIC's short list.
Guzman y Gomez Short Interest Hits 13.9% Despite Positive Update
Quick-service restaurant Guzman y Gomez (ASX: GYG) has 13.9% short interest, rising week-on-week, with concerns over its US business despite better-than-expected results. Short sellers remain unconvinced. It ranks fourth on the ASX shorts list.
Treasury Wine Estates Maintains 13% Short Interest
Treasury Wine Estates (ASX: TWE) holds steady at 13% short interest after a positive trading update lifted shares, disappointing shorts. The wine giant faces ongoing bearish bets. ASIC data places it fifth most shorted.
Flight Centre Travel Group Short Interest at 12.5%
Flight Centre (ASX: FLT) has 12.5% short interest, down slightly, amid worries over Middle East conflict and higher airfares impacting travel demand. Short sellers eye potential slowdowns. It is sixth on ASIC's list.